LGC Awarded Ethical Status
LGC Standards has been awarded a Responsible Sourcing status by Sedex for its Standards division in Germany. A non-profit membership organization, Sedex is dedicated to improving responsible and ethical business practices in global supply chains.
LGC Standards (Middlesex, UK) has been awarded a Responsible Sourcing status by Sedex for its Standards division in Germany. A non-profit membership organization, Sedex is dedicated to improving responsible and ethical business practices in global supply chains.
“We take great pride in having our Responsible Sourcing status confirmed and are particularly pleased that our customers appreciate our Ethical Trading Initiative,” commented HansâChristian Schumacher, Managing Director of LGC’s Standards division.
With members in over 150 countries, Sedex is the largest collaborative platform for sharing ethical supply chain data. The online database allows companies to store, share, and report on information in the four key areas of labour standards, care of the environment, business ethics, and health and safety.
LGC employees across many departments underwent auditing by Sedex, with findings indicating LGC is an ethically run company with good workers rights and a commitment to reduce its burden upon the environment.
By informing customers on the ethical practices of companies, Sedex hopes to reduce risk and improve supply chain practices - simultaneously providing an efficient and cost-effective method of data sharing for companies.
For more information please visit www.lgcstandards.com and www.sedexglobal.com.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
